newsfilter
← Latest News
GlobeNewswire·

Passage Bio Announces 1-for-20 Reverse Stock Split

PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. ("Passage Bio" or the "Company") (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with